LIMN
Liminatus Pharma·NASDAQ
--
--(--)
--
--(--)
5.28 / 10
Netural
Financial evaluation shows mixed fundamentals for Liminatus Pharma, scoring 5.3/10. Key strengths include a solid interest-coverage ratio (EBIT/Interest expense = 15.48) and positive revenue-to-market value (Revenue-MV = -0.257), indicating healthy operating leverage and relative valuation benefits. However, a high Days sales outstanding (72.55) points to slower receivable collection, and the stock's PB-ROE (31.32) is elevated, hinting at potential overvaluation. Overall, the balance sheet and profitability remain adequate, but working-capital efficiency and valuation deserve monitoring.
Analysis Checks(9/10)
Revenue-MV
Value-0.26
Score3/3
Weight17.30%
1M Return10.54%
Value-0.26
Score3/3
Weight17.30%
1M Return10.54%
Days sales outstanding
Value72.55
Score1/3
Weight-1.90%
1M Return-1.57%
Value72.55
Score1/3
Weight-1.90%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight13.81%
1M Return8.45%
Value-0.17
Score2/3
Weight13.81%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.38%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.38%
1M Return-1.11%
Asset-MV
Value-0.50
Score3/3
Weight25.57%
1M Return13.15%
Value-0.50
Score3/3
Weight25.57%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.48%
1M Return1.11%
Value78.47
Score2/3
Weight1.48%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight13.79%
1M Return8.45%
Value0.46
Score2/3
Weight13.79%
1M Return8.45%
PB-ROE
Value31.32
Score2/3
Weight17.20%
1M Return9.14%
Value31.32
Score2/3
Weight17.20%
1M Return9.14%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.57%
1M Return0.43%
Value92.66
Score2/3
Weight0.57%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight13.56%
1M Return8.41%
Value-0.07
Score2/3
Weight13.56%
1M Return8.41%
Revenue-MV
Value-0.26
Score3/3
Weight17.30%
1M Return10.54%
Value-0.26
Score3/3
Weight17.30%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight1.48%
1M Return1.11%
Value78.47
Score2/3
Weight1.48%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-1.90%
1M Return-1.57%
Value72.55
Score1/3
Weight-1.90%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight13.79%
1M Return8.45%
Value0.46
Score2/3
Weight13.79%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight13.81%
1M Return8.45%
Value-0.17
Score2/3
Weight13.81%
1M Return8.45%
PB-ROE
Value31.32
Score2/3
Weight17.20%
1M Return9.14%
Value31.32
Score2/3
Weight17.20%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.38%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.38%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.57%
1M Return0.43%
Value92.66
Score2/3
Weight0.57%
1M Return0.43%
Asset-MV
Value-0.50
Score3/3
Weight25.57%
1M Return13.15%
Value-0.50
Score3/3
Weight25.57%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight13.56%
1M Return8.41%
Value-0.07
Score2/3
Weight13.56%
1M Return8.41%
Is LIMN fundamentally strong?
- LIMN scores 5.28/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, 0.00% net margin, 0.00 P/E ratio, -30.26 P/B ratio, and 0.00% earnings growth, these metrics solidify its Netural investment rating.
